Clinical Trial Update: A Study of Acute Myocardial Infarction Using FDY-5301 [Phase 2]

View source ↗

Summary

Phase 2 study of FDY-5301 for acute myocardial infarction, including ST-elevation myocardial infarction; results were posted December 14, 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• St-elevation Myocardial Infarction

Drugs mentioned

• FDY-5301

Snippet

Sponsor: Faraday Pharmaceuticals, Inc. | Conditions: Acute Myocardial Infarction, STEMI | Phase 2 | Status: COMPLETED | Results posted: 2021-12-14